Common Contracts
3 similar Rights Agreement contracts
DealPointData.comRights Agreement • July 26th, 2022
On July 25, 2022, the Board of Directors (the “Board”) of Tabula Rasa HealthCare, Inc., a Delaware corporation (the “Company”), approved and adopted a Rights Agreement, dated as of July 25, 2022 (the “Rights Agreement”), by and between the Company and American Stock Transfer & Trust Company, LLC, as Rights Agent (the “Rights Agent”). Pursuant to the Rights Agreement, the Board declared a dividend of one preferred share purchase right (each, a “Right”) for each outstanding share of common stock, par value $0.0001, of the Company (each, a “Common Share” and, collectively, the “Common Shares”). The Rights are distributable to stockholders of record as of the close of business on August 5, 2022 (the “Record Date”). One Right also will be issued together with each Common Share issued by the Company after August 5, 2022, but before the Distribution Date (as defined below) (or the earlier redemption or expiration of the Rights) and, in certain circumstances, after the Distribution Date.
DealPointData.com ADMA Biologics, Inc.Rights Agreement • December 21st, 2021
On December 20, 2021, the Board of Directors (the “Board”) of ADMA Biologics, Inc., a Delaware corporation (the “Company”), approved and adopted a Rights Agreement, dated as of December 20, 2021 (the “Rights Agreement”), by and between the Company and Continental Stock Transfer and Trust Company, as rights agent. Pursuant to the Rights Agreement, the Board declared a dividend of one preferred share purchase right (each, a “Right”) for each outstanding share of common stock, par value $0.0001, of the Company (each, a “Common Share” and, collectively, the “Common Shares”). The Rights are distributable to stockholders of record as of the close of business on December 30, 2021 (the “Record Date”). One Right also will be issued together with each Common Share issued by the Company after December 30, 2021, but before the Distribution Date (as defined below) (or the earlier redemption or expiration of the Rights) and, in certain circumstances, after the Distribution Date.
DealPointData.com ADMA Biologics, Inc.Rights Agreement • December 16th, 2020
On December 16, 2020, the Board of Directors (the “Board”) of ADMA Biologics, Inc., a Delaware corporation (the “Company”), approved and adopted a Rights Agreement, dated as of December 16, 2020 (the “Rights Agreement”), by and between the Company and Continental Stock Transfer and Trust Company, as rights agent. Pursuant to the Rights Agreement, the Board declared a dividend of one preferred share purchase right (each, a “Right”) for each outstanding share of common stock, par value $0.0001, of the Company (each, a “Common Share” and, collectively, the “Common Shares”). The Rights are distributable to stockholders of record as of the close of business on December 30, 2020 (the “Record Date”). One Right also will be issued together with each Common Share issued by the Company after December 30, 2020, but before the Distribution Date (as defined below) (or the earlier redemption or expiration of the Rights) and, in certain circumstances, after the Distribution Date.
